Cargando…
A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction
NK recognition is regulated by a delicate balance between positive signals initiating their effector functions, and inhibitory signals preventing them from proceeding to cytolysis. Knowledge of the molecules responsible for positive signaling in NK cells is currently limited. We demonstrate that IL-...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196353/ https://www.ncbi.nlm.nih.gov/pubmed/9182676 |
_version_ | 1782148047013150720 |
---|---|
author | Carbone, Ennio Ruggiero, Giuseppina Terrazzano, Giuseppe Palomba, Carmen Manzo, Ciro Fontana, Silvia Spits, Hergen Kärre, Klas Zappacosta, Serafino |
author_facet | Carbone, Ennio Ruggiero, Giuseppina Terrazzano, Giuseppe Palomba, Carmen Manzo, Ciro Fontana, Silvia Spits, Hergen Kärre, Klas Zappacosta, Serafino |
author_sort | Carbone, Ennio |
collection | PubMed |
description | NK recognition is regulated by a delicate balance between positive signals initiating their effector functions, and inhibitory signals preventing them from proceeding to cytolysis. Knowledge of the molecules responsible for positive signaling in NK cells is currently limited. We demonstrate that IL-2–activated human NK cells can express CD40 ligand (CD40L) and that recognition of CD40 on target cells can provide an activation pathway for such human NK cells. CD40-transfected P815 cells were killed by NK cell lines expressing CD40L, clones and PBLderived NK cells cultured for 18 h in the presence of IL-2, but not by CD40L-negative fresh NK cells. Cross-linking of CD40L on IL-2–activated NK cells induced redirected cytolysis of CD40-negative but Fc receptor-expressing P815 cells. The sensitivity of human TAP-deficient T2 cells could be blocked by anti-CD40 antibodies as well as by reconstitution of TAP/MHC class I expression, indicating that the CD40-dependent pathway for NK activation can be downregulated, at least in part, by MHC class I molecules on the target cells. NK cell recognition of CD40 may be important in immunoregulation as well as in immune responses against B cell malignancies. |
format | Text |
id | pubmed-2196353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21963532008-04-16 A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction Carbone, Ennio Ruggiero, Giuseppina Terrazzano, Giuseppe Palomba, Carmen Manzo, Ciro Fontana, Silvia Spits, Hergen Kärre, Klas Zappacosta, Serafino J Exp Med Article NK recognition is regulated by a delicate balance between positive signals initiating their effector functions, and inhibitory signals preventing them from proceeding to cytolysis. Knowledge of the molecules responsible for positive signaling in NK cells is currently limited. We demonstrate that IL-2–activated human NK cells can express CD40 ligand (CD40L) and that recognition of CD40 on target cells can provide an activation pathway for such human NK cells. CD40-transfected P815 cells were killed by NK cell lines expressing CD40L, clones and PBLderived NK cells cultured for 18 h in the presence of IL-2, but not by CD40L-negative fresh NK cells. Cross-linking of CD40L on IL-2–activated NK cells induced redirected cytolysis of CD40-negative but Fc receptor-expressing P815 cells. The sensitivity of human TAP-deficient T2 cells could be blocked by anti-CD40 antibodies as well as by reconstitution of TAP/MHC class I expression, indicating that the CD40-dependent pathway for NK activation can be downregulated, at least in part, by MHC class I molecules on the target cells. NK cell recognition of CD40 may be important in immunoregulation as well as in immune responses against B cell malignancies. The Rockefeller University Press 1997-06-16 /pmc/articles/PMC2196353/ /pubmed/9182676 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Article Carbone, Ennio Ruggiero, Giuseppina Terrazzano, Giuseppe Palomba, Carmen Manzo, Ciro Fontana, Silvia Spits, Hergen Kärre, Klas Zappacosta, Serafino A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title | A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title_full | A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title_fullStr | A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title_full_unstemmed | A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title_short | A New Mechanism of NK Cell Cytotoxicity Activation: The CD40–CD40 Ligand Interaction |
title_sort | new mechanism of nk cell cytotoxicity activation: the cd40–cd40 ligand interaction |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2196353/ https://www.ncbi.nlm.nih.gov/pubmed/9182676 |
work_keys_str_mv | AT carboneennio anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT ruggierogiuseppina anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT terrazzanogiuseppe anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT palombacarmen anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT manzociro anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT fontanasilvia anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT spitshergen anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT karreklas anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT zappacostaserafino anewmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT carboneennio newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT ruggierogiuseppina newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT terrazzanogiuseppe newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT palombacarmen newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT manzociro newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT fontanasilvia newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT spitshergen newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT karreklas newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction AT zappacostaserafino newmechanismofnkcellcytotoxicityactivationthecd40cd40ligandinteraction |